3 solid buy and hold stocks to build long-term wealth

Westpac Banking Corp (ASX:WBC), Platinum Asset Management Limited (ASX:PTM) and CSL Limited (ASX:CSL) are good choices for growth.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Creating a portfolio that can build up long-term compounded growth requires some buy and hold stocks that can steadily grow without a lot of ups and downs.

"Buy and hold" doesn't mean "buy and forget" or, even worse, "buy and hope (it goes up)". Rather, regular reading and research on each stock can't be neglected. Reading company reports and updates gives you a view about how the stock story is improving (or slipping).

You would want a company with solid earning power that could continue for 10, 20 years or more. Also, having a strong brand name to attract new customers and maintain earnings growth is always a big plus. You don't want to have to trade in and out of these buy and hold stocks. Ideally, you would add to each shareholding position over the years, especially during market downturns when you can buy good stocks on the cheap.

Westpac Banking Corp (ASX: WBC) is one suitable choice. The big four bank has given shareholders a total annualised return of 13.2% over the past five years – that's higher than the ASX's average long-term return. The stock pays a fully franked 5.3% yield and has a decent track record for dividend growth. I like the bank's exposure to international markets because that diversifies its revenues to maintain overall earnings growth.

Still within the financial service sector, Platinum Asset Management Limited (ASX: PTM) has shown renewed earnings strength in the past few years. This asset manager specialises in international equities, which are growing faster than the domestic market here. It manages about $25 billion of client assets and funds. Financial year 2014 was a remarkable year, achieving high-double digit earnings growth, thanks to some overseas markets like the U.S. hitting new all-time index highs.

Among healthcare stocks, CSL Limited (ASX: CSL) has kept up its long-term track record for business expansion. The biopharmaceutical produces blood related medical supplies and treatments for viral diseases. Its products are in high demand in overseas markets, where the majority of its revenue is generated. It is expanding its facilities in Australia, Germany and the U.S. to meet the demand. CSL's earnings are forecast to grow an average annual 16.7% over the next two years. I particularly like the long-term growth potential, so CSL should be high on investors' watchlists.

Motley Fool contributor Darryl Daté-Shappard does not own shares in any company mentioned. 

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »